Cerenome is trading 12.16% up in pre-market at $1.75, compared with its October 5 close of $1.56; no clear company-specific catalyst for the October 6 move was identified.
- The latest filing located was an October 2 investor presentation; recent coverage also referenced the September 30 business update. Neither establishes a direct reason for the gain.
- Broader U.S. indices are higher, but the supplied market figures are below the stated threshold for attributing the move to broad-market sentiment.